OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Innate Immune Recognition of Cancer
Seng‐Ryong Woo, Leticia Corrales, Thomas F. Gajewski
Annual Review of Immunology (2015) Vol. 33, Iss. 1, pp. 445-474
Open Access | Times Cited: 520
Seng‐Ryong Woo, Leticia Corrales, Thomas F. Gajewski
Annual Review of Immunology (2015) Vol. 33, Iss. 1, pp. 445-474
Open Access | Times Cited: 520
Showing 1-25 of 520 citing articles:
Elements of cancer immunity and the cancer–immune set point
Daniel S. Chen, Ira Mellman
Nature (2017) Vol. 541, Iss. 7637, pp. 321-330
Closed Access | Times Cited: 4327
Daniel S. Chen, Ira Mellman
Nature (2017) Vol. 541, Iss. 7637, pp. 321-330
Closed Access | Times Cited: 4327
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten, Sergei I. Grivennikov
Immunity (2019) Vol. 51, Iss. 1, pp. 27-41
Open Access | Times Cited: 2801
Florian R. Greten, Sergei I. Grivennikov
Immunity (2019) Vol. 51, Iss. 1, pp. 27-41
Open Access | Times Cited: 2801
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 2032
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 2032
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1739
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1739
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey, Ling Tong, Yulin Li, et al.
Science (2016) Vol. 352, Iss. 6282, pp. 227-231
Open Access | Times Cited: 1172
Stephanie C. Casey, Ling Tong, Yulin Li, et al.
Science (2016) Vol. 352, Iss. 6282, pp. 227-231
Open Access | Times Cited: 1172
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour, Michael Karin
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3347-3355
Open Access | Times Cited: 633
Shabnam Shalapour, Michael Karin
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3347-3355
Open Access | Times Cited: 633
Regulatory circuits of T cell function in cancer
Daniel E. Speiser, Ping‐Chih Ho, Grégory Verdeil
Nature reviews. Immunology (2016) Vol. 16, Iss. 10, pp. 599-611
Closed Access | Times Cited: 499
Daniel E. Speiser, Ping‐Chih Ho, Grégory Verdeil
Nature reviews. Immunology (2016) Vol. 16, Iss. 10, pp. 599-611
Closed Access | Times Cited: 499
Kuppusamy Balamurugan
International Journal of Cancer (2015) Vol. 138, Iss. 5, pp. 1058-1066
Open Access | Times Cited: 493
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan, Cary F. Opel, Gregory L. Szeto, et al.
Nature Medicine (2016) Vol. 22, Iss. 12, pp. 1402-1410
Open Access | Times Cited: 490
Kelly D. Moynihan, Cary F. Opel, Gregory L. Szeto, et al.
Nature Medicine (2016) Vol. 22, Iss. 12, pp. 1402-1410
Open Access | Times Cited: 490
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Böttcher, Caetano Reis e Sousa
Trends in cancer (2018) Vol. 4, Iss. 11, pp. 784-792
Open Access | Times Cited: 442
Jan P. Böttcher, Caetano Reis e Sousa
Trends in cancer (2018) Vol. 4, Iss. 11, pp. 784-792
Open Access | Times Cited: 442
Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
Haidong Tang, Yang Wang, Lukasz K. Chlewicki, et al.
Cancer Cell (2016) Vol. 29, Iss. 3, pp. 285-296
Open Access | Times Cited: 422
Haidong Tang, Yang Wang, Lukasz K. Chlewicki, et al.
Cancer Cell (2016) Vol. 29, Iss. 3, pp. 285-296
Open Access | Times Cited: 422
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
Eileen E. Parkes, Steven M. Walker, Laura E. Taggart, et al.
JNCI Journal of the National Cancer Institute (2016) Vol. 109, Iss. 1, pp. djw199-djw199
Open Access | Times Cited: 412
Eileen E. Parkes, Steven M. Walker, Laura E. Taggart, et al.
JNCI Journal of the National Cancer Institute (2016) Vol. 109, Iss. 1, pp. djw199-djw199
Open Access | Times Cited: 412
Oncolytic viruses as engineering platforms for combination immunotherapy
Kwame Twumasi‐Boateng, Jessica L. Pettigrew, Young Kwok, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 7, pp. 419-432
Closed Access | Times Cited: 361
Kwame Twumasi‐Boateng, Jessica L. Pettigrew, Young Kwok, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 7, pp. 419-432
Closed Access | Times Cited: 361
Complement in cancer: untangling an intricate relationship
Edimara S. Reis, Dimitrios C. Mastellos, Daniel Ricklin, et al.
Nature reviews. Immunology (2017) Vol. 18, Iss. 1, pp. 5-18
Open Access | Times Cited: 358
Edimara S. Reis, Dimitrios C. Mastellos, Daniel Ricklin, et al.
Nature reviews. Immunology (2017) Vol. 18, Iss. 1, pp. 5-18
Open Access | Times Cited: 358
Immune crosstalk in cancer progression and metastatic spread: a complex conversation
Hannah Garner, Karin E. de Visser
Nature reviews. Immunology (2020) Vol. 20, Iss. 8, pp. 483-497
Closed Access | Times Cited: 328
Hannah Garner, Karin E. de Visser
Nature reviews. Immunology (2020) Vol. 20, Iss. 8, pp. 483-497
Closed Access | Times Cited: 328
Current status and future directions of cancer immunotherapy
Hongming Zhang, Jibei Chen
Journal of Cancer (2018) Vol. 9, Iss. 10, pp. 1773-1781
Open Access | Times Cited: 323
Hongming Zhang, Jibei Chen
Journal of Cancer (2018) Vol. 9, Iss. 10, pp. 1773-1781
Open Access | Times Cited: 323
Crosstalk between cancer and immune cells: Role of tumor‐associated macrophages in the tumor microenvironment
Jing Wang, Danyang Li, Huaixing Cang, et al.
Cancer Medicine (2019) Vol. 8, Iss. 10, pp. 4709-4721
Open Access | Times Cited: 300
Jing Wang, Danyang Li, Huaixing Cang, et al.
Cancer Medicine (2019) Vol. 8, Iss. 10, pp. 4709-4721
Open Access | Times Cited: 300
Harnessing tumor-associated macrophages as aids for cancer immunotherapy
Xiaolei Li, Rui Liu, Xiao Su, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 296
Xiaolei Li, Rui Liu, Xiao Su, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 296
Immunotherapy and tumor microenvironment
Haidong Tang, Jian Qiao, Yang‐Xin Fu
Cancer Letters (2015) Vol. 370, Iss. 1, pp. 85-90
Open Access | Times Cited: 272
Haidong Tang, Jian Qiao, Yang‐Xin Fu
Cancer Letters (2015) Vol. 370, Iss. 1, pp. 85-90
Open Access | Times Cited: 272
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling
Meng Xu, Pu Yang, Dali Han, et al.
Immunity (2017) Vol. 47, Iss. 2, pp. 363-373.e5
Open Access | Times Cited: 260
Meng Xu, Pu Yang, Dali Han, et al.
Immunity (2017) Vol. 47, Iss. 2, pp. 363-373.e5
Open Access | Times Cited: 260
Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and Can Be Targeted to Enhance Anti-tumor Response
Vijay K. Gonugunta, Tomomi Sakai, Vladislav Pokatayev, et al.
Cell Reports (2017) Vol. 21, Iss. 11, pp. 3234-3242
Open Access | Times Cited: 251
Vijay K. Gonugunta, Tomomi Sakai, Vladislav Pokatayev, et al.
Cell Reports (2017) Vol. 21, Iss. 11, pp. 3234-3242
Open Access | Times Cited: 251
Biomolecular Condensates and Cancer
Ann Boija, Isaac A. Klein, Richard A. Young
Cancer Cell (2021) Vol. 39, Iss. 2, pp. 174-192
Open Access | Times Cited: 244
Ann Boija, Isaac A. Klein, Richard A. Young
Cancer Cell (2021) Vol. 39, Iss. 2, pp. 174-192
Open Access | Times Cited: 244
Trial watch: STING agonists in cancer therapy
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 228
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 228
Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity
W. Joost Lesterhuis, Anthony Bosco, Michael Millward, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 4, pp. 264-272
Closed Access | Times Cited: 226
W. Joost Lesterhuis, Anthony Bosco, Michael Millward, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 4, pp. 264-272
Closed Access | Times Cited: 226
Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 225
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 225
